In July 2006, the Food and Drug Administration warned that women who use the antidepressant Zoloft after the 20th week of pregnancy are six times more likely to give birth to a child with persistent pulmonary hypertension of the newborn (PPHN). The FDA issued this warning about Zoloft based on the results of a study in the New England Journal of Medicine that examined the risk of birth defects with Zoloft and similar antidepressants.
Other studies have warned about the risk of heart defects or other birth defects among children whose mothers took Zoloft during pregnancy. Researchers have found that Zoloft users are more likely to give birth to a child with septal defects, ventricular outflow tract defects, craniosynostosis or omphalocele.
Zoloft may also increase the risk of other serious side effects, including patent ductus arteriosus (PDA), transposition of the great arteries, coarctation of the aorta, cardiomyopathy, hypoplastic left heart syndrome (HLHS), cleft mitral valve, Tetralogy of Fallot, bicuspid aortic valve or tricuspid stenosis.
Despite the FDA’s Zoloft warning about the link between the antidepressant and heart defects, the agency has not announced any plans to issue a Zoloft recall. The agency has advised women taking Zoloft who are or may become pregnant to speak with their doctor about the risks and benefits of continuing to take the drug.
If you or a loved one took Zoloft while pregnant and gave birth to a child with heart defects or other serious birth defects, contact the lawyers at Hissey Kientz, LLP for a free legal consultation. You can reach us by calling our toll-free hotline at 1-866-275-4454, or by filling out the free case evaluation form located on this page.